Good efficacy and safety of vedolizumab in Crohn’s disease and ulcerative colitis in a real-world scenario

Good efficacy and safety of vedolizumab in Crohn’s disease and ulcerative colitis in a real-world scenario

Background: Data on vedolizumab (VDZ) use in inflammatory bowel disease (IBD) patients are still limited. We aimed to assess the effectiveness and tolerability of VDZ in a real-life clinical scenario. Methods: We retrospectively collected data of all consecutive IBD patients who started VDZ from Sep...

Full description

Bibliographic Details
Main Authors: Fabiana Zingone, Brigida Barberio, Federico Compostella, Giulia Girardin, Renata D’Incà, Carla Marinelli, Ilaria Marsilio, Greta Lorenzon, Edoardo Vincenzo Savarino
Format: Article
Language:English
Published: SAGE Publishing 2020-07-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/1756284820936536

Internet

https://doi.org/10.1177/1756284820936536

Similar Items